
Sino Biological/SARS-CoV-2(2019 nCoV)Spike S1+S2 ECD His重组蛋白/1/40589-V08B1
商品编号:
40589-V08B1
品牌:
sinobiological
市场价:
¥0.00
美元价:
0.00
联系Q Q:
3392242852
电话号码:
4000-520-616
电子邮箱:
info@ebiomall.com
商品介绍
SARS-CoV-2 (2019-nCoV) Spike S1+S2 ECD-His Recombinant Protein: Product Information
Purity
> 90 % as determined by SDS-PAGE.
Endotoxin
< 1.0="" eu="" per="" μg="" protein="" as="" determined="" by="" the="" lal="">
Activity
The 2019-nCoV Spike Protein (S1+S2 ECD, His tag) can bind with Human ACE2 in functional ELISA assay.
Protein Construction
A DNA sequence encoding the SARS-CoV-2 (2019-nCoV) Spike Protein (S1+S2 ECD) (YP_009724390.1) (Val 16-Pro1213) was expressed with a polyhistidine tag at the C-terminus.
Accession#
YP_009724390.1
Expressed Host
Baculovirus-Insect Cells
Species
2019-nCoV
Predicted N Terminal
Val 16
Molecule Mass
The recombinant SARS-CoV-2 (2019-nCoV) Spike Protein (S1+S2 ECD, His tag) consists of 1209 amino acids and predicts a molecular mass of 134.36 kDa.
Formulation
Lyophilized from sterile 20 mM Tris, 300 mM NaCl, 10 % glycerol, pH 8.0.Please contact us for any concerns or special requirements. Normally 5 % - 8 % trehalose, mannitol and 0.01% Tween80 are added as protectants before lyophilization.
Please refer to the specific buffer information in the hard copy of CoA.
Shipping
In general, recombinant proteins are provided as lyophilized powder which are shipped at ambient temperature.Bulk packages of recombinant proteins are provided as frozen liquid. They are shipped out with blue ice unless customers require otherwise.
Stability & Storage
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
Reconstitution
A hardcopy of COA with reconstitution instruction is sent along with the products. Please refer to it for detailed information.
SARS-CoV-2 (2019-nCoV) Spike S1+S2 ECD-His Recombinant Protein: Images


Measured by its binding ability in a functional ELISA. Immobilized human ACE2 protein (Fc tag) (10108-H05H) at 2 μg/mL (100 μL/well) can bind SARS-CoV-2 (2019-nCoV) Spike S1+S2 ECD-His (40589-V08B1), the EC50 of SARS-CoV-2 (2019-nCoV) Spike S1+S2 ECD-His (40589-V08B1) is 400-1200 ng/mL.
SARS-CoV-2 (2019-nCoV) Spike S1+S2 ECD-His Recombinant Protein: Synonyms
coronavirus spike Protein, 2019-nCoV; cov spike Protein, 2019-nCoV; ncov RBD Protein, 2019-nCoV; ncov s1 Protein, 2019-nCoV; ncov s2 Protein, 2019-nCoV; ncov spike Protein, 2019-nCoV; NCP-CoV RBD Protein, 2019-nCoV; NCP-CoV s1 Protein, 2019-nCoV; NCP-CoV s2 Protein, 2019-nCoV; NCP-CoV Spike Protein, 2019-nCoV; novel coronavirus RBD Protein, 2019-nCoV; novel coronavirus s1 Protein, 2019-nCoV; novel coronavirus s2 Protein, 2019-nCoV; novel coronavirus spike Protein, 2019-nCoV; RBD Protein, 2019-nCoV; S1 Protein, 2019-nCoV; S2 Protein, 2019-nCoV; Spike RBD Protein, 2019-nCoV
Coronavirus spike Background Information
The spike (S) glycoprotein of coronaviruses contains protrusions that will only bind to certain receptors on the host cell. Known receptors bind S1 are ACE2, angiotensin-converting enzyme 2; DPP4, dipeptidyl peptidase-4; APN, aminopeptidase N; CEACAM, carcinoembryonic antigen-related cell adhesion molecule 1; Sia, sialic acid; O-ac Sia, O-acetylated sialic acid. The spike is essential for both host specificity and viral infectivity. The term "peplomer" is typically used to refer to a grouping of heterologous proteins on the virus surface that function together. The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. It"s been reported that SARS-CoV-2 (COVID-19 coronavirus, 2019-nCoV) can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion. The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity. The main functions for the Spike protein are summarized as: Mediate receptor binding and membrane fusion; Defines the range of the hosts and specificity of the virus; Main component to bind with the neutralizing antibody; Key target for vaccine design; Can be transmitted between different hosts through gene recombination or mutation of the receptor binding domain (RBD), leading to a higher mortality rate.
References
- Shen S, et al. (2007) Expression, glycosylation, and modification of the spike (S) glycoprotein of SARS CoV. Methods Mol Biol. 379: 127-35.
- Du L, et al. (2009) The spike protein of SARS-CoV--a target for vaccine and therapeutic development. Nat Rev Microbiol. 7 (3): 226-36.
- Xiao X, et al. (2004) The SARS-CoV S glycoprotein. Cell Mol Life Sci. 61 (19-20): 2428-30.
SARS Coronavirus spike Proteins
- SARS-CoV Spike S2-His Recombinant Protein40150-V08B3
- SARS-CoV Spike/S1 Protein (S1 Subunit, His Tag)40150-V08B1
- SARS-CoV Spike/RBD Protein (RBD, His Tag)40150-V08B2
- SARS-CoV Spike/RBD Protein (RBD, mFc Tag)40150-V05H
- SARS-CoV Spike/S1 Protein (S1 Subunit, mFc Tag)40150-V05H1
- SARS-CoV Spike S1+S2 ECD-His Recombinant Protein (S577A, Isolate Tor2)40634-V08B
- SARS-CoV Spike/S1 Protein (S1 Subunit, His Tag), Biotinylated40150-V08B1-B
- SARS-CoV Spike/RBD Protein (RBD, rFc Tag)40150-V31B2
- SARS-CoV Spike/RBD Protein (RBD, His Tag), Biotinylated40150-V08B2-B
2019-nCoV Coronavirus spike Proteins
- SARS-CoV-2 (2019-nCoV) Spike RBD(A348S)-His Recombinant Protein40592-V08H25
- SARS-CoV-2 (2019-nCoV) Spike RBD-His Recombinant Protein, Biotinylated40592-V08B-B
- SARS-CoV-2 (2019-nCoV) Spike RBD(A520S)-His Recombinant Protein40592-V08H20
- SARS-CoV-2 (2019-nCoV) Spike RBD(Y508H)-His Recombinant Protein40592-V08H12
- SARS-CoV-2 (2019-nCoV) Spike S2-mFc Recombinant Protein40590-V05B
- SARS-CoV-2 (2019-nCoV) Spike S1+S2 ECD (R683A, R685A, F817P, A892P, A899P, A942P, K986P, V987P)-His Recombinant Protein40589-V08H4
- SARS-CoV-2 (2019-nCoV) Spike RBD(K378R)-His Recombinant Protein40592-V08H33
- SARS-CoV-2 (2019-nCoV) Spike RBD(Q409E)-His Recombinant Protein40592-V08H34
- SARS-CoV-2 (2019-nCoV) Spike RBD(A372T)-His Recombinant Protein40592-V08H36
- SARS-CoV-2 (2019-nCoV) Spike RBD(E406Q)-His Recombinant Protein40592-V08H40
- SARS-CoV-2 (2019-nCoV) Spike RBD(K378N)-His Recombinant Protein40592-V08H42
- SARS-CoV-2 (2019-nCoV) Spike RBD(F338L)-His Recombinant Protein40592-V08H26
- SARS-CoV-2 (2019-nCoV) Spike RBD(A522V)-His Recombinant Protein40592-V08H16
- SARS-CoV-2 (2019-nCoV) Spike RBD(F456L)-His Recombinant Protein40592-V08H71
- SARS-CoV-2 (2019-nCoV) Spike RBD(F486S)-His Recombinant Protein40592-V08H74
- SARS-CoV-2 (2019-nCoV) Spike RBD(P337S)-His Recombinant Protein40592-V08H62
- SARS-CoV-2 (2019-nCoV) Spike RBD(K444R)-His Recombinant Protein40592-V08H54
- SARS-CoV-2 (2019-nCoV) Spike S1 NTD-His & AVI Recombinant Protein, Biotinylated40591-V49H-B
- SARS-CoV-2 (2019-nCoV) Spike S1 NTD-His & AVI Recombinant Protein40591-V49H
- SARS-CoV-2 (2019-nCoV) Spike RBD(N487R)-His Recombinant Protein40592-V08H75
- SARS-CoV-2 (2019-nCoV) Spike RBD(E484Q)-His Recombinant Protein40592-V08H81
- SARS-CoV-2 (2019-nCoV) Spike RBD(F490L)-His Recombinant Protein40592-V08H83
- SARS-CoV-2 (2019-nCoV) Spike S1(L18F, D614G)-His Recombinant Protein40591-V08H6
- SARS-CoV-2 (2019-nCoV) Spike RBD(L455F)-His Recombinant Protein40592-V08H68
- SARS-CoV-2 (2019-nCoV) Spike S1(A222V, D614G)-His Recombinant Protein40591-V08H4
- SARS-CoV-2 (2019-nCoV) Spike RBD(G446S)-His Recombinant Protein40592-V08H76
- SARS-CoV-2 (2019-nCoV) Spike S1-His Recombinant Protein40591-V08B1
- SARS-CoV-2 (2019-nCoV) Spike RBD(P521S)-His Recombinant Protein40592-V08H29
- SARS-CoV-2 (2019-nCoV) Spike S1-His Recombinant Protein (HPLC-verified)40591-V08H
- SARS-CoV-2 (2019-nCoV) Spike RBD-His Recombinant Protein40592-V08B
- SARS-CoV-2 (2019-nCoV) Spike RBD-His (N354D) Recombinant Protein40592-V08H2
- SARS-CoV-2 (2019-nCoV) Spike RBD(I472V)-His Recombinant Protein40592-V08H35
- SARS-CoV-2 (2019-nCoV) Spike S1(D614G),ECD-Fc Recombinant Protein40591-V02H3
- SARS-CoV-2 (2019-nCoV) Spike RBD(S477R)-His Recombinant Protein40592-V08H64
- SARS-CoV-2 (2019-nCoV) Spike RBD-His (K458R) Recombinant Protein40592-V08H7
- SARS-CoV-2 (2019-nCoV) Spike RBD(L452R)-His Recombinant Protein40592-V08H28
- SARS-CoV-2 (2019-nCoV) Spike RBD(T478I)-His Recombinant Protein40592-V08H30
- SARS-CoV-2 (2019-nCoV) Spike RBD(V483I)-His Recombinant Protein40592-V08H31
- SARS-CoV-2 (2019-nCoV) Spike RBD(S477N)-His Recombinant Protein40592-V08H46
- SARS-CoV-2 (2019-nCoV) Spike RBD(T385A)-His Recombinant Protein40592-V08H47
- SARS-CoV-2 (2019-nCoV) Spike RBD-His (A435S) Recombinant Protein40592-V08H4
- SARS-CoV-2 (2019-nCoV) Spike RBD(N481D)-His Recombinant Protein40592-V08H70
- SARS-CoV-2 (2019-nCoV) Spike RBD(D405V, Q414A)-His Recombinant Protein40592-V08H22
- SARS-CoV-2 (2019-nCoV) Spike RBD(A352S)-His Recombinant Protein40592-V08H58
- SARS-CoV-2 (2019-nCoV) Spike S1 NTD-Fc & AVI Recombinant Protein, Biotinylated40591-V41H-B
- SARS-CoV-2 (2019-nCoV) Spike S1(HV69-70 deletion, N501Y, D614G)-His Recombinant Protein40591-V08H7
- SARS-CoV-2 (2019-nCoV) Spike S1(HV69-70 deletion, Y453F, D614G)-His Recombinant Protein40591-V08H8
- SARS-CoV-2 (2019-nCoV) Spike RBD(E484K)-His Recombinant Protein40592-V08H84
- SARS-CoV-2 (2019-nCoV) Spike S2 ECD(708S-1207E)-His Recombinant Protein40590-V08H1
- SARS-CoV-2 (2019-nCoV) Spike RBD-His (F342L) Recombinant Protein40592-V08H6
- SARS-CoV-2 (2019-nCoV) Spike RBD-His (V367F) Recombinant Protein40592-V08H1
- SARS-CoV-2 (2019-nCoV) Spike RBD-His (V483A) Recombinant Protein40592-V08H5
- SARS-CoV-2 (2019-nCoV) Spike RBD(F377L)-His Recombinant Protein40592-V08H27
- SARS-CoV-2 (2019-nCoV) Spike RBD(S477I)-His Recombinant Protein40592-V08H45
- SARS-CoV-2 (2019-nCoV) Spike S2 ECD-Fc Recombinant Protein40590-V02H
- SARS-CoV-2 (2019-nCoV) Spike RBD(E471Q)-His Recombinant Protein40592-V08H56
- SARS-CoV-2 (2019-nCoV) Spike RBD-mFc Recombinant Protein (HPLC-verified)40592-V05H
- SARS-CoV-2 (2019-nCoV) Spike RBD(A520V)-His Recombinant Protein40592-V08H39
- SARS-CoV-2 (2019-nCoV) Spike RBD(A344S)-His Recombinant Protein40592-V08H37
- SARS-CoV-2 (2019-nCoV) Spike RBD(N439K)-His Recombinant Protein40592-V08H14
- SARS-CoV-2 (2019-nCoV) Spike RBD(N440K)-His Recombinant Protein40592-V08H55
- SARS-CoV-2 (2019-nCoV) Spike RBD(K417N)-His Recombinant Protein40592-V08H59
- SARS-CoV-2 (2019-nCoV) Spike RBD(P521R)-His Recombinant Protein40592-V08H63
- SARS-CoV-2 (2019-nCoV) Spike RBD-AVI & His Recombinant Protein, Biotinylated40592-V27B-B
- SARS-CoV-2 (2019-nCoV) Spike RBD-His (W436R) Recombinant Protein40592-V08H9
- SARS-CoV-2 (2019-nCoV) Spike RBD(Y453F)-His Recombinant Protein40592-V08H80
- SARS-CoV-2 (2019-nCoV) Spike RBD(N501Y)-His Recombinant Protein40592-V08H82
- SARS-CoV-2 (2019-nCoV) Spike S1(K417N, E484K, N501Y, D614G)-His Recombinant Protein40591-V08H10
- SARS-CoV-2 (2019-nCoV) Spike RBD-rFc Recombinant Protein40592-V31H
- SARS-CoV-2 (2019-nCoV) Spike S1(D614G)-His Recombinant Protein, HPLC-verified40591-V08H3
- SARS-CoV-2 (2019-nCoV) Spike S2 ECD-His Recombinant Protein40590-V08B
- SARS-CoV-2 (2019-nCoV) Spike S2 ECD-His Recombinant Protein, Biotinylated40590-V08B-B
- SARS-CoV-2 (2019-nCoV) Spike RBD(Q414E)-His Recombinant Protein40592-V08H23
- SARS-CoV-2 (2019-nCoV) Spike RBD-mFc (V367F) Recombinant Protein40592-V05H1
- SARS-CoV-2 (2019-nCoV) Spike S1+S2 ECD (D614G)-His Recombinant Protein40589-V08B4
- SARS-CoV-2 (2019-nCoV) Spike RBD(V341I)-His Recombinant Protein40592-V08H11
- SARS-CoV-2 (2019-nCoV) Spike RBD(V503F)-His Recombinant Protein40592-V08H15
- SARS-CoV-2 (2019-nCoV) Spike RBD(V395I)-His Recombinant Protein40592-V08H49
- SARS-CoV-2 (2019-nCoV) Spike RBD(G482S)-His Recombinant Protein40592-V08H53
- SARS-CoV-2 (2019-nCoV) Spike RBD(K458Q)-His Recombinant Protein40592-V08H69
- SARS-CoV-2 (2019-nCoV) Spike RBD(F456E)-His Recombinant Protein40592-V08H73
- SARS-CoV-2 (2019-nCoV) Spike RBD(F490S)-His Recombinant Protein40592-V08H41
- SARS-CoV-2 (2019-nCoV) Spike RBD(S359N)-His Recombinant Protein40592-V08H32
- SARS-CoV-2 (2019-nCoV) Spike RBD(P384L)-His Recombinant Protein40592-V08H24
- SARS-CoV-2 (2019-nCoV) Spike RBD(T393P)-His Recombinant Protein40592-V08H48
- SARS-CoV-2 (2019-nCoV) Spike S1 NTD-Fc & AVI Recombinant Protein40591-V41H
- SARS-CoV-2 (2019-nCoV) Spike RBD-His Recombinant Protein40592-V08H
- SARS-CoV-2 (2019-nCoV) Spike S1-Fc Recombinant Protein40591-V02H
- SARS-CoV-2 (2019-nCoV) Spike RBD(A475V)-His Recombinant Protein40592-V08H50
- SARS-CoV-2 (2019-nCoV) Spike RBD(V445F)-His Recombinant Protein40592-V08H79
- SARS-CoV-2 (2019-nCoV) Spike S1(N234Q)-His Recombinant Protein40591-V08H11
- SARS-CoV-2 (2019-nCoV) Spike S1(T20N, D614G)-His Recombinant Protein40591-V08H5
- SARS-CoV-2 (2019-nCoV) Spike RBD Recombinant Protein40592-VNAH
- SARS-CoV-2 (2019-nCoV) Spike RBD-His Recombinant Protein,Biotinylated40592-V08H-B
- SARS-CoV-2 (2019-nCoV) Spike RBD(R408I)-His Recombinant Protein40592-V08H10
- SARS-CoV-2 (2019-nCoV) Spike RBD(A522S)-His Recombinant Protein40592-V08H21
- SARS-CoV-2 (2019-nCoV) Spike S1-His Recombinant Protein, Biotinylated40591-V08H-B
- SARS-CoV-2 (2019-nCoV) Spike S1+S2 ECD-His Recombinant Protein, Biotinylated40589-V08B1-B
- SARS-CoV-2 (2019-nCoV) Spike RBD-Fc Recombinant Protein (HPLC-verified)40592-V02H
- SARS-CoV-2 (2019-nCoV) Spike RBD(G446V)-His Recombinant Protein40592-V08H51
- SARS-CoV-2 (2019-nCoV) Spike RBD(G476S)-His Recombinant Protein40592-V08H8
- SARS-CoV-2 (2019-nCoV) Spike RBD(N370S)-His Recombinant Protein40592-V08H43
- SARS-CoV-2 (2019-nCoV) Spike RBD(Q414R)-His Recombinant Protein40592-V08H44
- SARS-CoV-2 (2019-nCoV) Spike RBD(S494P)-His Recombinant Protein40592-V08H18
- SARS-CoV-2 (2019-nCoV) Spike RBD(A372S)-His Recombinant Protein40592-V08H19
- SARS-CoV-2 (2019-nCoV) Spike RBD(Y505C)-His Recombinant Protein40592-V08H72
- SARS-CoV-2 (2019-nCoV) Spike RBD(G485S)-His Recombinant Protein40592-V08H52
- SARS-CoV-2 (2019-nCoV) Spike RBD(P479S)-His Recombinant Protein40592-V08H57
- SARS-CoV-2 (2019-nCoV) Spike S1+S2 ECD-AVI & His Recombinant Protein, Biotinylated40589-V27B-B
- SARS-CoV-2 (2019-nCoV) Spike S1-mFc Recombinant Protein40591-V05H1
- SARS-CoV-2 (2019-nCoV) Spike RBD(P499R)-His Recombinant Protein40592-V08H78
- SARS-CoV-2 (2019-nCoV) Spike S1(HV69-70 deletion, Y144 deletion, N501Y, A570D, D614G, P681H)-His Recombinant Protein40591-V08H12
- SARS-CoV-2 (2019-nCoV) Spike S1-AVI & His Recombinant Protein, Biotinylated40591-V27H-B
- SARS-CoV-2 (2019-nCoV) Spike RBD-AVI & His Recombinant Protein, Biotinylated40592-V27H-B
HCoV-OC43 Coronavirus spike Proteins
- Human coronavirus (HCoV-OC43) Spike Protein (S1+S2 ECD, His Tag)40607-V08B
- Human coronavirus (HCoV-OC43) Spike S2 Protein (ECD, His Tag)40607-V08B1
- Human coronavirus (HCoV-OC43) Spike S1 Protein (His Tag)40607-V08H1
MERS-CoV Coronavirus spike Proteins
- MERS-CoV Spike/S1 Protein (S1 Subunit, aa 1-725, His Tag)40069-V08B1
- MERS-CoV Spike/RBD Protein fragment (RBD, aa 367-606, His Tag)40071-V08B1
- MERS-CoV Spike Protein (S1+S2 ECD, aa 1-1297, His Tag)40069-V08B
- MERS-CoV Spike/RBD Protein fragment (RBD, aa 367-606, His Tag), Biotinylated40071-V08B1-B
- MERS-CoV Spike/S1 Protein (S1 Subunit, aa 1-725, His Tag), HPLC-verifiedHPLC-40069-V08H
- MERS-CoV Spike/RBD Protein fragment (RBD, aa 367-606, rFc Tag)40071-V31B1
- MERS-CoV Spike/S1 Protein (S1 Subunit, aa 1-725, His Tag)40069-V08H
- MERS-CoV Spike/S2 Protein (S2 Subunit, aa 726-1296, His Tag)40070-V08B
HCoV-HKU1 Coronavirus spike Proteins
- Human coronavirus HKU1 (isolate N5) (HCoV-HKU1) Spike/S1 Protein (S1 Subunit, His Tag)40602-V08H
- Human coronavirus HKU1 (isolate N1) (HCoV-HKU1) Spike/S1 Protein (S1 Subunit, His Tag)40021-V08H
- Human coronavirus HKU1 (isolate N5) (HCoV-HKU1) Spike Protein (S1+S2 ECD, His Tag)40606-V08B
HCoV-NL63 Coronavirus spike Proteins
- Human coronavirus (HCoV-NL63) Spike Protein (S1+S2 ECD, His Tag)40604-V08B
- Human coronavirus (HCoV-NL63) Spike/S1 Protein (S1 Subunit, His Tag)40600-V08H
HCoV-229E Coronavirus spike Proteins
- Human coronavirus (HCoV-229E) Spike Protein (S1+S2 ECD, His Tag)40605-V08B
- Human coronavirus (HCoV-229E) Spike/S1 Protein (S1 Subunit, His Tag)40601-V08H
- Analysis of SARS-CoV-2 Antibodies in COVID-19 Convalescent Blood using a Coronavirus Antigen MicroarrayAuthorDe Assis, RR;Jain, A;Nakajima, R;Jasinskas, A;Year2020JournalBioRxivFoldedExpand
- Analysis of Serologic Cross-Reactivity Between Common Human Coronaviruses and SARS-CoV-2 Using Coronavirus Antigen MicroarrayAuthorKhan, S;Nakajima, R;Jain, A;De Assis, RR;Jasinskas, A;Year2020JournalBioRxivFoldedExpand
- Cholesterol Metabolism--Impact for SARS-CoV-2 Infection Prognosis, Entry, and Antiviral TherapiesAuthorWei, C;Wan, L;Zhang, Y;Fan, C;Yan, Q;Yang, X;Gong, J;Year2020JournalmedRxivFoldedExpand
- COVID-19 serology at population scale: SARS-CoV-2-specific antibody responses in salivaAuthorRandad, PR;Pisanic, N;Kruczynski, K;Manabe, YC;Year2020JournalmedRxivFoldedExpand
- Discovery of Aptamers Targeting Receptor-Binding Domain of the SARS-CoV-2 Spike GlycoproteinAuthorSong, Y;Song, J;Wei, X;Huang, M;Sun, M;Zhu, L;Lin, B;Shen, H;Zhu, Z;Yang, C;Year2020JournalChemRxivFoldedExpand
- Eltrombopag is a potential target for drug intervention in SARS-CoV-2 spike proteinAuthorFeng, S;Luan, X;Wang, Y;Wang, H;Zhang, Z;Wang, Y;Tian, Z;Liu, M;Xiao, Y;Zhao, Y;Zhou, R;Zhang, S;Year2020JournalInfect. Genet. Evol.PubMed ID: 32540428FoldedExpand
- Humanized Single Domain Antibodies Neutralize SARS-CoV-2 by Targeting Spike Receptor Binding DomainAuthorChi, X;Liu, X;Wang, C;Zhang, X;Ren, L;Jin, Q;Wang, J;Year2020JournalbioRxivFoldedExpand
- Immunogenicity of a DNA vaccine candidate for COVID-19AuthorSmith, TRF;Patel, A;Ramos, S;Elwood, D;Zhu, X;Yan, J;Gary, EN;Walker, SN;Schultheis, K;Purwar, M;Xu, Z;Walters, J;Bhojnagarwala, P;Yang, M;Chokkalingam, N;Pezzoli, P;Parzych, E;Reuschel, EL;Doan, A;Tursi, N;Vasquez, M;Choi, J;Tello-Ruiz, E;Maricic, I;Bah, MA;Wu, Y;Amante, D;Park, DH;Dia, Y;Ali, AR;Zaidi, FI;Generotti, A;Kim, KY;Herring, TA;Reeder, S;Andrade, VM;Buttigieg, K;Zhao, G;Wu, JM;Li, D;Bao, L;Liu, J;Deng, W;Qin, C;Brown, AS;Khoshnejad, M;Wang, N;Chu, J;Wrapp, D;McLellan, JS;Muthumani, K;Wang, B;Carroll, MW;Kim, JJ;Boyer, J;Kulp, DW;Humeau, LMPF;Weiner, DB;Broderick, KE;Year2020JournalNat CommunPubMed ID: 32433465FoldedExpand
- Potent neutralizing antibodies against SARS-CoV-2 identified by high-throughput single-cell sequencing of convalescent patients" B cellsAuthorCao, Y;Su, B;Guo, X;Sun, W;Deng, Y;Bao, L;Zhu, Q;Zhang, X;Zheng, Y;Geng, C;Chai, X;He, R;Li, X;Lv, Q;Zhu, H;Deng, W;Xu, Y;Wang, Y;Qiao, L;Tan, Y;Song, L;Wang, G;Du, X;Gao, N;Liu, J;Xiao, J;Su, XD;Du, Z;Feng, Y;Qin, C;Qin, C;Jin, R;Xie, XS;Year2020JournalCellPubMed ID: 32425270FoldedExpand
- SARS-CoV-2 spike protein binds heparan sulfate in a length-and sequence-dependent mannerAuthorLiu, L;Chopra, P;Li, X;Wolfert, MA;Tompkins, SM;Year2020JournalbioRxivApplicationSPRFoldedExpand
- Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins using High-Resolution Mass SpectrometryAuthorZhang, Y;Zhao, W;Mao, Y;Wang, S;Zhong, Y;Su, T;Year2020JournalbioRxivFoldedExpand
- Synthetic nanobodies targeting the SARS-CoV-2 receptor-binding domainAuthorWalter, JD;Hutter, CAJ;Zimmermann, I;Earp, J;Egloff, P;Year2020JournalBioRxivFoldedExpand
- Assessing the application of a pseudovirus system for emerging SARS-CoV-2 and re-emerging avian influenza virus H5 subtypes in vaccine developmentAuthorHuang, S;Tai, C;Hsu, Y;Cheng, D;Hung, S;Chai, K;Wang, Y;Wang, J;Year2020JournalBiomedical JournalFoldedExpand
- SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen PreparednessAuthorCorbett, K;Edwards, D;Leist, S;Abiona, O;Boyoglu-Barnum, S;Gillespie, R;Himansu, S;Schäfer, A;Ziwawo, C;DiPiazza, A;Dinnon, K;Elbashir, S;Shaw, C;Woods, A;Fritch, E;Martinez, D;Bock, K;Minai, M;Nagata, B;Hutchinson, G;Bahl, K;Garcia-Dominguez, D;Ma, L;Renzi, I;Kong, W;Schmidt, S;Wang, L;Zhang, Y;Stevens, L;Phung, E;Chang, L;Loomis, R;Altaras, N;Narayanan, E;Metkar, M;Presnyak, V;Liu, C;Louder, M;Shi, W;Leung, K;Yang, E;West, A;Gully, K;Wang, N;Wrapp, D;Doria-Rose, N;Stewart-Jones, G;Bennett, H;Nason, M;Ruckwardt, T;McLellan, J;Denison, M;Chappell, J;Moore, I;Morabito, K;Mascola, J;Baric, R;Carfi, A;Graham, B;Year2020JournalbioRxivApplicationimmunizationFoldedExpand
- SARS-CoV-2 environmental contamination associated with persistently infected COVID-19 patientsAuthorLei, H;Ye, F;Liu, X;Huang, Z;Ling, S;Jiang, Z;Cheng, J;Huang, X;Wu, Q;Wu, S;Xie, Y;Xiao, C;Ye, D;Yang, Z;Li, Y;Leung, NHL;Cowling, BJ;He, J;Wong, SS;Zanin, M;Year2020JournalInfluenza Other Respir VirusesApplicationElisaPubMed ID: 32578948FoldedExpand
- SARS-CoV-2 assays to detect functional antibody responses that block ACE2 recognition in vaccinated animals and infected patientsAuthorWalker, S;Chokkalingam, N;Reuschel, E;Purwar, M;Xu, Z;Gary, E;Kim, K;Schultheis, K;Walters, J;Ramos, S;Smith, T;Broderick, K;Tebas, P;Patel, A;Weiner, D;Kulp, D;Year2020JournalbioRxivApplicationElisaFoldedExpand
- Array-based analysis of SARS-CoV-2, other coronaviruses, and influenza antibodies in convalescent COVID-19 patientsAuthorSteiner, D;Cognetti, J;Luta, E;Klose, A;Bucukovski, J;Bryan, M;Schmuke, J;Nguyen-Contant, P;Sangster, M;Topham, D;Miller, B;Year2020JournalbioRxivFoldedExpand
- Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patientAuthorZhou, D;Duyvesteyn, H;Chen, C;Huang, C;Chen, T;Shih, S;Lin, Y;Cheng, C;Cheng, S;Huang, Y;Lin, T;Ma, C;Huo, J;Carrique, L;Malinauskas, T;Ruza, R;Shah, P;Tan, T;Rijal, P;Donat, R;Godwin, K;Buttigieg, K;Tree, J;Radecke, J;Paterson, N;Supasa, P;Mongkolsapaya, J;Screaton, G;Carroll, M;Jaramillo, J;Knight, M;James, W;Owens, R;Naismith, J;Townsend, A;Fry, E;Zhao, Y;Ren, J;Stuart, D;Huang, K;Year2020JournalbioRxivApplicationElisaFoldedExpand
- Insight into vaccine development for Alpha-coronaviruses based on structural and immunological analyses of spike proteinsAuthorShi, Y;Shi, J;Sun, L;Tan, Y;Wang, G;Guo, F;Hu, G;Fu, Y;Fu, Z;Xiao, S;Peng, G;Year2020JournalbioRxivApplicationAnimal immunization; ElisaFoldedExpand
- A single dose of an adenovirus-vectored vaccine provides complete protection of the upper and lower respiratory tracts against SARS-CoV-2 challengeAuthorWu, S;Zhong, G;Zhang, J;Shuai, L;Zhang, Z;Wen, Z;Wang, B;Zhao, Z;Song, X;Chen, Y;Liu, R;Fu, L;Zhang, J;Guo, Q;Wang, C;Yang, Y;Fang, T;Lv, P;Wang, J;Xu, J;Li, J;Yu, C;Hou, L;Bu, Z;Chen, W;Year2020JournalResearch SquareFoldedExpand
- Characterization of heparin and severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) spike glycoprotein binding interactionsAuthorKim, SY;Jin, W;Sood, A;Montgomery, DW;Grant, OC;Fuster, MM;Fu, L;Dordick, JS;Woods, RJ;Zhang, F;Linhardt, RJ;Year2020JournalAntiviral Res.ApplicationSPRPubMed ID: 32653452FoldedExpand
- SARS-CoV-2 surveillance for a non-human primate breeding research facilityAuthorYee, JL;Van Rompay, KKA;Carpenter, AB;Nham, PB;Halley, BM;Iyer, SS;Hartigan-O"Connor, DJ;Miller, CJ;Roberts, JA;Year2020JournalJ. Med. Primatol.ApplicationElisaPubMed ID: 32621339FoldedExpand
- A glycan cluster on the SARS-CoV-2 spike ectodomain is recognized by Fab-dimerized glycan-reactive antibodiesAuthorAcharya, P;Williams, W;Henderson, R;Janowska, K;Manne, K;Parks, R;Deyton, M;Sprenz, J;Stalls, V;Kopp, M;Mansouri, K;Edwards, RJ;Meyerhoff, RR;Oguin, T;Sempowski, G;Saunders, K;Haynes, BF;Year2020JournalbioRxivApplicationElisaPubMed ID: 32637953FoldedExpand
- A glycan cluster on the SARS-CoV-2 spike ectodomain is recognized by Fab-dimerized glycan-reactive antibodiesAuthorAcharya, P;Williams, W;Henderson, R;Janowska, K;Manne, K;Parks, R;Deyton, M;Sprenz, J;Stalls, V;Kopp, M;Mansouri, K;Edwards, RJ;Meyerhoff, RR;Oguin, T;Sempowski, G;Saunders, K;Haynes, BF;Year2020JournalbioRxivPubMed ID: 32637953FoldedExpand
- Structures of potent and convergent neutralizing antibodies bound to the SARS-CoV-2 spike unveil a unique epitope responsible for exceptional potencyAuthorDu, S;Cao, Y;Zhu, Q;Wang, G;Du, X;He, R;Xu, H;Zheng, Y;Wang, B;Bai, Y;Ji, C;Yisimayi, A;Wang, Q;Gao, N;Xie, X;Su, X;Xiao, J;Year2020JournalbioRxivFoldedExpand
- Modified Vaccinia Ankara Based SARS-CoV-2 Vaccine Expressing Full-Length Spike Induces Strong Neutralizing Antibody ResponseAuthorRouthu, N;Gangadhara, S;Cheedarla, N;Shiferaw, A;Rahman, S;Sahoo, A;Shi, P;Menachery, V;Floyd, K;Fischinger, S;Atyeo, C;Alter, G;Suthar, M;Amara, R;Year2020JournalbioRxivFoldedExpand
- Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike ProteinsAuthorZhang, Y;Zhao, W;Mao, Y;Chen, Y;Wang, S;Zhong, Y;Su, T;Gong, M;Du, D;Lu, X;Cheng, J;Yang, H;Year2020JournalbioRxivApplicationN-glycosylation Characterization by MSFoldedExpand
- Quantum Dot-Conjugated SARS-CoV-2 Spike Pseudo-Virions Enable Tracking of Angiotensin Converting Enzyme 2 Binding and EndocytosisAuthorGorshkov, K;Susumu, K;Chen, J;Xu, M;Pradhan, M;Zhu, W;Hu, X;Breger, JC;Wolak, M;Oh, E;Year2020JournalACS NanoPubMed ID: 32845122FoldedExpand
- SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2AuthorClausen, TM;Sandoval, DR;Spliid, CB;Pihl, J;Painter, CD;Thacker, BE;Glass, CA;Narayanan, A;Majowicz, SA;Zhang, Y;Torres, JL;Golden, GJ;Porell, R;Garretson, AF;Laubach, L;Feldman, J;Yin, X;Pu, Y;Hauser, B;Caradonna, TM;Kellman, BP;Martino, C;Gordts, PLSM;Leibel, SL;Chanda, SK;Schmidt, AG;Godula, K;Jose, J;Corbett, KD;Ward, AB;Carlin, AF;Esko, JD;Year2020JournalbioRxivPubMed ID: 32699853FoldedExpand
If you couldn"t find the specific citation, you can:
- Find All Citations
- Submit a CitationGet a Publication Reward
- Leave Us a Message
E.coli protein expression service
Mammalian transient protein expression service
Baculovirus-insect expression service
Stable cell line development service (CHO / HEK293)
品牌介绍
北京义翘神州科技股份有限公司(Sino Biological Inc.)是一家从事生物试剂研发、生产、销售并提供技术服务的生物科技公司,主要业务包括重组蛋白、抗体、基因和培养基等产品,以及重组蛋白、抗体的开发和生物分析检测等服务。义翘神州为全球的药品研发企业和生命科学研究机构提供高质量的生物试剂产品和高水平的技术服务。公司目前生产和销售的现货产品种类超过 4.6 万种,其中重组蛋白约 6,000 种,包括超过 3,800 种人源细胞表达重组蛋白产品,能够全面满足客户对于最接近人体天然蛋白结构和性质的重组蛋白需求;公司还能提供约 12,000 种抗体,其中单克隆抗体数量约 4,600 种,能够覆盖生命科学研究的多个领域,为分子生物学、细胞生物学、免疫学、发育生物学、干细胞研究等基础科研方向和创新药物研发提供「一站式」生物试剂产品和技术服务。义翘神州的客户涵盖大学、科研院所、医药研发企业等国内外各类生物研发单位。目前公司已经在美国、欧洲建立了子公司,已成为生物试剂行业国内领先的科技公司之一。
联络我们